Published in J Antimicrob Chemother on July 30, 2013
Clinical trials of medicines in neonates: the influence of ethical and practical issues on design and conduct. Br J Clin Pharmacol (2015) 0.84
Challenges in the diagnosis and management of neonatal sepsis. J Trop Pediatr (2015) 0.83
High variability in the dosing of commonly used antibiotics revealed by a Europe-wide point prevalence study: implications for research and dissemination. BMC Pediatr (2015) 0.80
Platelet parameters and (1, 3)-β-D-glucan as a diagnostic and prognostic marker of invasive fungal disease in preterm infants. PLoS One (2015) 0.75
Treatment with milk fat globule epidermal growth factor-factor 8 (MFG-E8) reduces inflammation and lung injury in neonatal sepsis. Surgery (2017) 0.75
Voriconazole treatment for less-common, emerging, or refractory fungal infections. Clin Infect Dis (2003) 3.70
Group B streptococcal disease in infants aged younger than 3 months: systematic review and meta-analysis. Lancet (2012) 2.98
Improved outcome in central nervous system aspergillosis, using voriconazole treatment. Blood (2005) 2.97
Primary care of children: the unique role of GPs. Br J Gen Pract (2012) 2.76
Revaccination with measles, tetanus, poliovirus, Haemophilus influenzae type B, meningococcus C, and pneumococcus vaccines in children after hematopoietic stem cell transplantation. Clin Infect Dis (2007) 2.45
Morbidity, mortality, and response to treatment by children in the United Kingdom and Ireland with perinatally acquired HIV infection during 1996-2006: planning for teenage and adult care. Clin Infect Dis (2007) 2.35
Increasing short-stay unplanned hospital admissions among children in England; time trends analysis '97-'06. PLoS One (2009) 2.24
PENTA 2009 guidelines for the use of antiretroviral therapy in paediatric HIV-1 infection. HIV Med (2009) 2.16
Pharmacokinetics and safety of intravenous voriconazole in children after single- or multiple-dose administration. Antimicrob Agents Chemother (2004) 2.08
Psychiatry and the human sciences. Br J Psychiatry (2003) 2.02
Post-traumatic stress and disability. Br J Psychiatry (2004) 2.02
Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children. Pediatr Infect Dis J (2002) 1.97
PEPtalk: postexposure prophylaxis against varicella in children with cancer. Arch Dis Child (2011) 1.91
Characterization of group B streptococci recovered from infants with invasive disease in England and Wales. Clin Infect Dis (2004) 1.91
Improving the quality of antibiotic prescribing in the NHS by developing a new Antimicrobial Stewardship Programme: Start Smart--Then Focus. J Antimicrob Chemother (2012) 1.86
The new UK antimicrobial resistance strategy and action plan. BMJ (2013) 1.86
Population pharmacokinetic analysis of voriconazole plasma concentration data from pediatric studies. Antimicrob Agents Chemother (2008) 1.79
Invasive Haemophilus influenzae Disease, Europe, 1996-2006. Emerg Infect Dis (2010) 1.77
Estimating Haemophilus influenzae type b vaccine effectiveness in England and Wales by use of the screening method. J Infect Dis (2003) 1.76
Acutely and retrospectively diagnosed perinatal stroke: a population-based study. Stroke (2007) 1.75
Infections due to Aspergillus terreus: a multicenter retrospective analysis of 83 cases. Clin Infect Dis (2004) 1.74
Treatment of scedosporiosis with voriconazole: clinical experience with 107 patients. Antimicrob Agents Chemother (2008) 1.69
Neonatal infections in England: the NeonIN surveillance network. Arch Dis Child Fetal Neonatal Ed (2010) 1.69
Placental phenotypes of intrauterine growth. Pediatr Res (2005) 1.68
Response to highly active antiretroviral therapy varies with age: the UK and Ireland Collaborative HIV Paediatric Study. AIDS (2004) 1.67
CD4 cell count and the risk of AIDS or death in HIV-Infected adults on combination antiretroviral therapy with a suppressed viral load: a longitudinal cohort study from COHERE. PLoS Med (2012) 1.54
An overview of global GBS epidemiology. Vaccine (2013) 1.47
Risk factors for late onset gram-negative infections: a case-control study. Arch Dis Child Fetal Neonatal Ed (2010) 1.47
Haemophilus influenzae type b vaccine--booster campaign. BMJ (2003) 1.46
Development and inter-rater reliability of the Liverpool adverse drug reaction causality assessment tool. PLoS One (2011) 1.45
Anaphylaxis as an adverse event following immunisation in the UK and Ireland. Arch Dis Child (2012) 1.42
Long-term immunological follow-up of children with haemophilus influenzae serotype b vaccine failure in the United Kingdom. Clin Infect Dis (2009) 1.42
X-linked lymphoproliferative disease due to SAP/SH2D1A deficiency: a multicenter study on the manifestations, management and outcome of the disease. Blood (2010) 1.40
Outcomes for human immunodeficiency virus-1-infected infants in the United kingdom and Republic of Ireland in the era of effective antiretroviral therapy. Pediatr Infect Dis J (2006) 1.33
Revaccination of children after completion of standard chemotherapy for acute leukemia. Clin Infect Dis (2007) 1.30
Haemophilus influenzae type b vaccine failure in children is associated with inadequate production of high-quality antibody. Clin Infect Dis (2008) 1.26
Adverse drug reactions and off-label and unlicensed medicines in children: a nested case-control study of inpatients in a pediatric hospital. BMC Med (2013) 1.25
Safety of voriconazole and dose individualization. Clin Infect Dis (2003) 1.23
Young people in the United Kingdom and Ireland with perinatally acquired HIV: the pediatric legacy for adult services. AIDS Patient Care STDS (2009) 1.23
Effect of antibiotics for otitis media on mastoiditis in children: a retrospective cohort study using the United kingdom general practice research database. Pediatrics (2009) 1.22
Antibiotic therapy for pediatric community-acquired pneumonia: do we know when, what and for how long to treat? Pediatr Infect Dis J (2012) 1.19
Pharmacokinetics, safety, and tolerability of voriconazole in immunocompromised children. Antimicrob Agents Chemother (2010) 1.18
Voriconazole for invasive bone aspergillosis: a worldwide experience of 20 cases. Clin Infect Dis (2005) 1.15
Adverse drug reactions causing admission to a paediatric hospital. PLoS One (2012) 1.11
Rate of CD4 decline and HIV-RNA change following HIV seroconversion in men who have sex with men: a comparison between the Beijing PRIMO and CASCADE cohorts. J Acquir Immune Defic Syndr (2013) 1.10
Use of pneumococcal polysaccharide vaccine in children: what is the evidence? Curr Opin Infect Dis (2012) 1.09
High neonatal concentrations of raltegravir following transplacental transfer in HIV-1 positive pregnant women. AIDS (2010) 1.09
Effect of tenofovir disoproxil fumarate on risk of renal abnormality in HIV-1-infected children on antiretroviral therapy: a nested case-control study. AIDS (2010) 1.09
Incidence, etiology, and outcome of bacterial meningitis in infants aged <90 days in the United kingdom and Republic of Ireland: prospective, enhanced, national population-based surveillance. Clin Infect Dis (2014) 1.08
Incidence, characteristics and risk factors of adverse drug reactions in hospitalized children - a prospective observational cohort study of 6,601 admissions. BMC Med (2013) 1.07
Improving the outcome of neonatal meningitis. Curr Opin Infect Dis (2009) 1.06
Mechanism-based urinary biomarkers to identify the potential for aminoglycoside-induced nephrotoxicity in premature neonates: a proof-of-concept study. PLoS One (2012) 1.04
Predictors of immune response and reactogenicity to AS03B-adjuvanted split virion and non-adjuvanted whole virion H1N1 (2009) pandemic influenza vaccines. Vaccine (2011) 1.02
Immunogenicity and induction of immunological memory of the heptavalent pneumococcal conjugate vaccine in preterm UK infants. Vaccine (2006) 1.02
Use of antibacterial agents in the neonate: 50 years of experience with vancomycin administration. Semin Fetal Neonatal Med (2012) 1.01
Using antibiotics responsibly: right drug, right time, right dose, right duration. J Antimicrob Chemother (2011) 1.01
CCL3L1 copy number is a strong genetic determinant of HIV seropositivity in Caucasian intravenous drug users. J Infect Dis (2010) 1.00
Off-label antibiotic use in children in three European countries. Eur J Clin Pharmacol (2010) 1.00
The antibiotic resistance and prescribing in European Children project: a neonatal and pediatric antimicrobial web-based point prevalence survey in 73 hospitals worldwide. Pediatr Infect Dis J (2013) 0.99
Nevirapine use in HIV-1-infected children. AIDS (2003) 0.99
Ciprofloxacin use in neonates: a systematic review of the literature. Pediatr Infect Dis J (2011) 0.98
Manipulation of drugs to achieve the required dose is intrinsic to paediatric practice but is not supported by guidelines or evidence. BMC Pediatr (2013) 0.97
A local reaction at or near injection site: case definition and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine (2008) 0.97
Risk factors associated with gut and nasopharyngeal colonization by common Gram-negative species and yeasts in neonatal intensive care units patients. Early Hum Dev (2011) 0.96
Using incidence assays within the context of the recent infections testing algorithm. AIDS (2014) 0.96
Oral penicillin prescribing for children in the UK: a comparison with BNF for Children age-band recommendations. Br J Gen Pract (2014) 0.96
Improving antibiotic prescribing in neonatal units: time to act. Arch Dis Child Fetal Neonatal Ed (2010) 0.95
Drug utilisation pattern and off-label use of medicines in Estonian neonatal units. Eur J Clin Pharmacol (2011) 0.94
Use of stored dried blood spots for retrospective diagnosis of congenital CMV. J Med Virol (2009) 0.94
Haplotype mapping of the bronchiolitis susceptibility locus near IL8. Hum Genet (2003) 0.94
Risk-benefit analysis of restricting antimicrobial prescribing in children: what do we really know? Curr Opin Infect Dis (2010) 0.93
Preventing severe respiratory syncytial virus disease: passive, active immunisation and new antivirals. Arch Dis Child (2014) 0.93
Postnatal head growth in preterm infants: a randomized controlled parenteral nutrition study. Pediatrics (2013) 0.93
Neonatal and pediatric antimicrobial stewardship programs in Europe-defining the research agenda. Pediatr Infect Dis J (2013) 0.93
Haemophilus influenzae type b reemergence after combination immunization. Emerg Infect Dis (2006) 0.92
Inflicted traumatic brain injury (ITBI) or shaken baby syndrome (SBS) in Estonia. Acta Paediatr (2006) 0.92
Group B streptococcal carriage, serotype distribution and antibiotic susceptibilities in pregnant women at the time of delivery in a refugee population on the Thai-Myanmar border. BMC Infect Dis (2012) 0.91
Genetic variation at the IL10 gene locus is associated with severity of respiratory syncytial virus bronchiolitis. J Infect Dis (2005) 0.91
Antibiotic prescribing for upper respiratory infections: European primary paediatricians' knowledge, attitudes and practice. Acta Paediatr (2012) 0.91
Significantly increasing hospital admissions for acute throat infections among children in England: is this related to tonsillectomy rates? Arch Dis Child (2012) 0.91
Antibiotic dosing in children in Europe: can we grade the evidence from pharmacokinetic/pharmacodynamic studies - and when is enough data enough? Curr Opin Infect Dis (2012) 0.90
Acute haematogenous osteomyelitis in children: is there any evidence for how long we should treat? Curr Opin Infect Dis (2008) 0.89
GABAergic system gene expression predicts clinical outcome in patients with neuroblastoma. J Clin Oncol (2004) 0.89
Nodule at injection site as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation. Vaccine (2004) 0.89
People living with HIV in Estonia: engagement in HIV care in 2013. Euro Surveill (2016) 0.89
Steroids fail to down-regulate respiratory syncytial virus-induced IL-8 secretion in infants. Pediatr Res (2002) 0.89
Association between single-nucleotide polymorphisms in Mal/TIRAP and interleukin-10 genes and susceptibility to invasive haemophilus influenzae serotype b infection in immunized children. Clin Infect Dis (2010) 0.89
Variants of the chemokine receptor CCR5 are associated with severe bronchiolitis caused by respiratory syncytial virus. J Infect Dis (2003) 0.89
H1N1 antibody persistence 1 year after immunization with an adjuvanted or whole-virion pandemic vaccine and immunogenicity and reactogenicity of subsequent seasonal influenza vaccine: a multicenter follow-on study. Clin Infect Dis (2012) 0.89
The changing aetiology of paediatric bacteraemia in England and Wales, 1998-2007. J Med Microbiol (2009) 0.89
Framework conditions facilitating paediatric clinical research. Ital J Pediatr (2011) 0.88